Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory Data
NCT03078049
·
clinicaltrials.gov ↗
COMPLETED
Status
11971
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes Mellitus Type 2
Sponsor
AstraZeneca
Collaborators
[object Object]